KEGG   DRUG: Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugatedHelp
Entry
D10535                      Drug                                   

Name
Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated;
Menactra (TN);
Nimenrix (TN)
Remark
Therapeutic category: 6311
ATC code: J07AH08
Product: D10535<JP>
Efficacy
Active immunization (pneumococcal)
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AH Meningococcal vaccines
     J07AH08 Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
      D10535  Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6311  Bacterial vaccines
     D10535  Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10535
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10535
BRITE hierarchy
Other DBs
PubChem: 254741497
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system